News Center

Home page

Peak Report

News reports

Announcement on the progress of entrusted financial management

Release time:

2020-08-05

证券简称：尖峰集团证券代码：600668 编号：临2019-004

债券简称：13尖峰02 债券代码：122344

浙江尖峰集团股份有限公司

关于委托理财进展情况的公告

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。

重要内容提示：

l 委托理财受托方：广发银行股份有限公司金华分行

l 委托理财金额：5000万元人民币

l 委托理财投资类型：保本浮动收益型结构性存款

l 委托理财期限：2019年1月29日—2019年4月29日

一、本次委托理财概述

（一）本次委托理财的基本情况

公司于2019年1月29日与广发银行股份有限公司金华分行（以下简称“广发银行金华分行”）签署《广发银行“薪加薪16号”人民币结构性存款合同》，公司出资5,000万元人民币购买广发银行金华分行发售的人民币结构性存款XJXCKJ5811号产品，产品期限90天，预期年化收益率4.15%，本产品为保本浮动收益型产品。

公司本次投资委托理财产品的资金为运营中暂时闲置的自有资金，进行短期委托理财，能提高资金使用效率。本次委托理财不构成关联交易。

（二）公司内部需履行的审批程序。

2018年4月20日，公司召开的第十届董事会第3次会议审议通过了《关于授权公司董事长决定委托理财的议案》。授权公司董事长行使不超过人民币3亿元的委托理财的决策权，在该额度内资金可以滚动使用，但任一时点存续的委托理财余额合计不得超过3亿元，每笔委托理财的期限均不得超过12个月。详见本公司在2018年4月24日在上海证券交易所网站披露的《关于授权董事长决定委托理财的公告》（临2018-007）。

公司本次购买广发银行金华分行发售的单位结构性存款XJXCKJ5811理财产品，在公司第十届董事会第3次会议授权董事长决策范围之内。

二、本次委托理财协议主体的基本情况

（一）交易对方名称：广发银行股份有限公司金华分行，公司类型：股份有限公司分公司（国有控股），营业场所：浙江省金华市婺城区八一南街999号赞佳大厦主楼1-4层、裙楼2-3层及4层局部，负责人：李振岳，经营范围：经营中国银行业监督管理委员会依照有关法律、行政法规和其他规定批准的业务，经营范围以批准文件所列的为准。（依法须经批准的项目，经相关部门批准后方可开展经营活动）

（二）广发银行股份有限公司金华分行与本公司之间在产权、业务、资产、债权债务、人员等方面均不存在关联关系。

三、本次委托理财合同的主要内容

（一）基本说明

公司本次购买理财产品的资金来源为公司自有资金，委托理财期限为2019年1月29日至2019年4月29日，该产品为保本浮动收益型结构性存款产品，预期年化收益率为2.6%或4.15%，无需提供履约担保。银行和投资者应各自承担其在本合同项下应交纳的税费。本产品收益的计算中已包含（计入）银行的运营管理成本（如账户监管、资金运作管理、交易手续费等），公司无需支付或承担本产品下的其他费用或收费。

（二）产品说明

1、投资方向及受益权比例

本结构性存款所募集的资金本金部分纳入广发银行金华分行资金统一运作管理，投资于货币市场工具（包括但不限于银行存款、拆借、回购等）的比例区间为20%-100%、债券（包括但不限于国债、央票、金融债、短期融资券、企业债、中期票据、公司债）等金融资产的比例区间为0%-80%，收益部分投资于与美元兑港币的汇率水平挂钩的金融衍生产品，投资者的结构性存款收益取决于美元兑港币的汇率在观察期间内的表现。

2、收益计算

结构性存款收益率与美元兑港币的最终汇率水平挂钩。美元兑港币的最终汇率是指2019年02月11日路透页面香港时间上午11：30“HKDFIX”公布的美元兑港币汇率。如果届时约定的数据提供商路透资讯（Reuters）页面不能给出适用的价格水平，或者用于价格水平确定的版面或时间发生变化，广发银行将本着公平、公正、公允的原则，选择市场认可的合理的价格水平进行计算。

汇率区间为（7.0000, 9.0000），即汇率区间下限为7.0000，汇率区间上限为9.0000。

结构性存款收益说明：

（1）如果美元兑港币的最终汇率始终位于汇率区间内（不含边界点），则到期时结构性存款收益率为4.15％（年化收益率）；

（2）如果美元兑港币的最终汇率始终位于汇率区间外（含边界点），则到期时结构性存款收益率为2.6％（年化收益率）。

结构性存款收益情景模拟：

	观察日美元兑港币的最终汇率P	年化收益率
情景一	P≥9.0000 或 P≤7.0000	2.6%
情景二	7.0000<P<9.0000	4.15%

投资者获得的结构性存款收益=结构性存款本金×到期年化收益率×实际结构性存款天数÷365，精确到小数点后2位。

3、提前终止：

本结构性存款存续期内，结构性存款投资者无提前终止权利。

4、提前赎回：

本结构性存款投资期间不设提前赎回，结构性存款投资者无提前赎回该结构性存款的权利。

5、本金及收益兑付：

本结构性存款成立且投资者持有该结构性存款直至到期日，则广发银行在结构性存款到期日向投资者偿付全部人民币本金，并按照规定向投资者支付结构性存款收益。

6、产品特点

本产品为保本浮动收益型结构性存款产品，风险较低，适合对于利率、汇率、商品价格等走势有一定见解和看法的投资人，在投资者持有到期的情况下银行保障客户本金安全，一定程度上降低了风险。

（三）敏感性分析

公司本次以自有资金5000万元购买的广发银行金华分行结构性存款XJXCKJ5811号产品期限较短，不会对公司生产经营状况造成影响。在该投资期限内减少公司现金流净额5000万元，到期后预期为公司产生收益51.16万元。

（四）风险控制分析

本产品为保本浮动收益型产品，银行确保公司本金安全，符合公司维护全体股东和公司利益的原则。公司始终将委托理财产品风险防控工作放在首位，严格按照内控制度有关规定，投资委托理财产品均为期限短、安全性高、流动性好的低风险银行理财产品。公司对购买的理财产品严格把关，谨慎决策。

（五）独立董事意见

公司召开的第十届董事会第3次会议审议通过了《关于授权公司董事长决定委托理财的议案》，独立董事发表了独立意见，认为：该决议的形成符合《公司法》、公司《章程》等有关规定，没有损害中小股东的利益。

四、公司累计进行的委托理财情况

公司曾于2018年11月17日，在《上海证券报》、《中国证券报》及上海证券交易所网站上披露了《关于委托理财进展情况的公告》。截至本公告日，公司已经收回了全部到期的委托理财。

前次进展公告后，截至本公告日，公司累计进行委托理财的金额为2.9亿元。详见下表：

序号	受托人	理财产品类型	金额（万元）	起始日	到期日	截止公告日已收回本金金额（万元）	截止公告日获得收益（万元）
1	渤海银行金华分行	渤海银行S181718号结构性存款产品	3,000.00	2018/12/7	2019/1/8	3,000.00	9.86
2	广发银行金华分行	薪加薪16号人民币结构性存款产品	4,000.00	2018/12/6	2019/1/7	4,000.00	13.33
3	交通银行金华分行	蕴通财富定期型结构性存款	5,000.00	2018/12/21	2019/1/25	5,000.00	18.70
4	广发银行金华分行	薪加薪16号人民币结构性存款产品	4,000.00	2019/1/4	2019/4/4	/	/
5	渤海银行金华分行	渤海银行S190019号结构性存款理财产品	4,000.00	2019/1/7	2019/4/8	/	/
6	民生银行金华分行	与利率挂钩的结构性存款产品	4,000.00	2019/1/8	2019/4/8	/	/
7	广发银行金华分行	薪加薪16号人民币结构性存款产品	5,000.00	2019/1/29	2019/4/29	/	/
合计			29,000.00	/	/	12,000.00	41.89

More information

Jianfeng Pharmaceutical Party Committee Commemorates 99th Anniversary of Party Founding

In order to celebrate the 99th anniversary of the founding of the Communist Party of China, on the afternoon of June 28, the Party committee of Jianfeng pharmaceutical company held a special commemorative activity. More than 100 Party members reviewed the oath of joining the party and listened to the special party class of "why can the Communist Party of China" delivered by Professor Zhang Wecai of the Party School of Jinhua municipal Party committee. At the beginning of the activity, Jin Huazhong, secretary of the Party Committee of Jianfeng Pharmaceutical, led all the participating party members to review the oath of joining the Party. He emphasized that the oath of joining the party is a solemn promise of every party member. As a party member, you must not forget your original intention, and compare the content of the oath in your work and life, constantly review, constantly reflect, strengthen self-examination, and use practical actions to fulfill your commitment to the party. Promise. On April 17, 2019, General Secretary Xi Jinping pointed out during an inspection in Chongqing: "We must focus on major issues such as why the Communist Party of China can, why Marxism can, and why socialism with Chinese characteristics is'good. 'Ideological and public opinion guidance." In order to enable party members to have a deeper understanding and understanding of this, the party committee of Jianfeng Pharmaceutical invited Professor Zhang Wancai, member of the School Affairs Committee and dean of the Jinhua Municipal Party School, to give a special lecture entitled "Why the Communist Party of China can. Professor Zhang reviewed the glorious history and great achievements of the Communist Party of China, combining theory with examples and current affairs, and expounded from the aspects of the Communist Party of China taking the people as the center, keeping in mind the mission of seeking happiness for the people, having the courage to self revolution and having historical responsibility. The content of his lectures was profound and simple, the classroom atmosphere was serious and earnest, and Party members were deeply enlightened. After the lecture, Jin Huazhong said in his concluding speech that the purpose of holding this commemorative event is to make all party members keep their vows in mind, strengthen theoretical guidance, strengthen ideals and beliefs, consciously practice the theme education of "not forgetting the original intention and keeping in mind the mission", and enhance all party members. Self-confidence in the road, theory, system, and culture. He stressed that the successful experience of the Communist Party of China, as a great organization, is of great practical significance to the reform and development of enterprises. Party organizations at all levels of Jianfeng Pharmaceutical should further strengthen the building of party branches and party members, further give full play to the political core role of party organizations and the vanguard and exemplary role of party members, promote the production and operation of enterprises with party building, and unite the broad masses of party members, cadres and all staff. devote themselves to all kinds of work with more enthusiasm, higher morale and more pragmatic style, and strive to achieve the annual work goals of the pharmaceutical company, together to build a better peak pharmaceutical industry. (Reporter Chen Shengmu)

2020

07-03

Jianfeng Pharmaceutical Party Committee Commemorates 99th Anniversary of Party Founding

2020

07-03

Jianfeng Pharmaceutical Party Committee Commemorates 99th Anniversary of Party Founding

2020

07-02

Jianfeng Pharmaceutical Party Committee Commemorates 99th Anniversary of Party Founding

2020

07-03

Jianfeng Pharmaceutical Party Committee Commemorates 99th Anniversary of Party Founding

2020

07-02

Spike Pharmaceuticals and its products won the annual "War Epidemic Double Star"

Recently, the results of the 2020 pharmaceutical industry "War Epidemic Star" public welfare selection activity were announced, Zhejiang Peak Pharmaceutical Company and its products injection penciclovir were selected at the same time, becoming the annual "War Epidemic Double Star". Since the outbreak of the new coronary pneumonia epidemic, Chinese pharmaceutical companies have shown their due commitment and dedication to the prevention and control of the epidemic, donating money and materials, developing drugs and developing vaccines. In order to bear in mind the enterprises that have made outstanding contributions in the epidemic prevention and control war, on April 24, the public welfare selection activity of "Star of War Epidemic" in the pharmaceutical industry in 2020 sponsored by the Medical Observer was officially launched. It lasted for more than a month and selected 10 pharmaceutical enterprises with the most social responsibility of "Star of War Epidemic" in 2020 and 10 BRICS varieties of "Star of War Epidemic" in 2020 respectively. As a listed company with a sense of social responsibility, Jianfeng Group takes "moral responsibility to help the world" as its corporate tenet. At the beginning of the outbreak, Jianfeng Group took the initiative to support the prevention and control of the epidemic. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries donated 700000 yuan in cash to medical institutions in Jinhua, Anhui and other places through various channels, as well as medical supplies such as protective clothing, gloves, medical masks, and disinfectants. In addition to targeted donations to medical institutions, at the beginning of the outbreak, the majority of employees of Peak Pharmaceuticals and its affiliated Jinhua Pharmaceutical Company and Peak Pharmacy gave up rest and organized the purchase of masks, alcohol, thermal guns, disinfectants, protective clothing and other epidemic prevention supplies through various channels. Penciclovir for injection, a product of Spike Pharmaceuticals, is the latest dosage form of open-loop nucleoside anti-herpes virus drugs.

2020

07-31

< 1...22 23 24...61 > 跳转到页